research reports and media, page-2655

If a shareholder can't reconcile the decision to what the company has previously stated then it's really appears to be on them.

Question: If the FDA is expected to accept PAR_008 data wouldn't you do what is being requested?

Timeframes may will move and you either set your expectations around this fact or you you'll continuously hit your head against the wall.

BTW PAR sentiment looks to be basing and setting up to turn a corner..... relatively soon is my guess on news of new CEO that shows an ability to reset the narrative. Either way the risk here is paramount our ability to be able to hold for the long haul. IMO DM is a given all the clinical trials to date where placebo can't be a factor. It's been surprising to see first hand how many vets know of the benefits of PPS and how they explain it.